A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques

A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide pandemic. Here, we present non-human primate immunogenicity and protective efficacy data generated with the capsid virus-like particle (cVLP)-based vaccine ABNCoV2 that has previously demonstrated immunogenicity in m...

Full description

Bibliographic Details
Main Authors: Ariane Volkmann, Gerrit Koopman, Petra Mooij, Ernst J. Verschoor, Babs E. Verstrepen, Willy M. J. M. Bogers, Manja Idorn, Søren R. Paludan, Søren Vang, Morten A. Nielsen, Adam F. Sander, Carolin Schmittwolf, Hubertus Hochrein, Paul Chaplin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Immunology
Subjects:
virus-like particles (VLP)
SARS-CoV-2
corona
COVID-19
broad neutralizing antibodies
protection
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.857440/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.857440/full

Similar Items